Quantitation and confirmation of the diazolo- and triazolobenzodiazepines in human urine by gas chromatography/mass spectrometry

Journal of Analytical Toxicology

Volumn 13, Issue 3, 1989, Pages 179-184

  Mule S J ^a   Casella, G A ^b  

^a New York State DSAS Testing and Research Laboratory ^*  (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; ALPRAZOLAM; BENZODIAZEPINE; BROMAZEPAM; DRUG METABOLITE; LORAZEPAM; MIDAZOLAM; NORDAZEPAM; OXAZEPAM; TRIAZOLAM;

DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METHODOLOGY; PRIORITY JOURNAL;

BENZODIAZEPINES; HUMAN; MASS FRAGMENTOGRAPHY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024324893     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/13.3.179     Document Type: Article

References (15)

1. D.J. Greenblatt, R.I. Shrader, and D.R. Abernathy. Current Status of Benzodiazepines, Parts 1 and 2. N. Engl. J. Med. 309:354–58, 410–16 (1983).
2. S. Cohen. The Benzodiazepines. Psychiatr. Ann. 13: 65–70 (1983).
3. L. Gerd and D.A. Puryear. Benzodiazepines—Misuse, abuse and dependency. Am. Fam. Physician 30: 139–47 (1984).
4. U. Busto, E.M. Sellers, C.A. Naranjo, H. Cappell, M. Sanchez-Craig, and K. Sykora. Withdrawal reaction after long term therapeutic use of benzodiazepines. N. Engl. J. Med. 315: 854–59 (1986).
5. W. Haefely. Biological basis of drug-induced tolerance, rebound and dependence. Contribution of recent research on benzodiazepines. Pharmacopsychiatry 19: 353–61 (1986).
6. T.H. Chiu, E.I. Tietz, and H.C. Rosenberg. Benzodiazepines, In Toxicology of CNS Depressants, I.K. Ho., Ed. CRC Press, Boco Raton, FL, 1987, pp. 1–32.
7. D.J. Greenblatt, M. Divoll, D.R. Abernathy, H.R. Ochs, and R.I. Shrader. Benzodiazepine pharmacokinetics: An Overview. In Drugs in Psychiatry, Vol. 2, G.D. Burrows, T.R. Norman, and B. Davies, Eds. Elsevier, New York, 1984, chapter 6.
8. K. Verebey, D. Jukofsky, and S.J. Mulé. Confirmation of EMIT Benzodiazepine Assays with GLC/NPD. J. Anal. Toxicol. 6:305–308 (1982).
9. M. Chiarotti, N. DeGiovanni, and A. Fiori. Analysis of Benzodiazepines, I. Chromatographic Identification. J. Chromatogr. 358: 169–78 (1986).
10. D.J. Greenblatt, K. Franke, and R.I. Shrader. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas–liquid chromatography. J. Chromatogr. 146: 311–20 (1978).
11. W.A. Joern and A.B. Joern. Detection of alprazolam (Xanax) and its metabolites in urine using dual capillary column, dual nitrogen detector gas chromatography. J. Anal. Toxicol. 11:247–51 (1987).
12. C.D. Syracuse, B.R. Kuhnert, and C.J. Kaine. Measurement of midazolam and α-hydroxymidazolam by gas chromatography with electron-capture detection. J. Chromatogr. 380:145–50 (1986).
13. J. Vasiliades. Midazolam determination by gas chromatography, liquid chromatography and gas chromatography-mass spectrometry. J. Chromatogr. 228: 195–203 (1982).
14. G. Koves and J. Wells. The quantitation of triazolam in postmortem blood by gas chromatography/negative ion chemical ionization mass spectrometry. J. Anal. Toxicol. 10: 241–44 (1986).
15. A.D. Fraser. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay. J. Anal. Toxicol. 11: 263–66 (1987).